Allergan plc (AGN) announced the release of new topline clinical trial data on Bimatoprost SR, the first-in-class sustained-release, biodegradable implant for the reduction of intraocular pressure or IOP in patients with open-angle glaucoma or ocular hypertension.
from RTT - Biotech https://ift.tt/2JFdigR
via IFTTT
No comments:
Post a Comment